Health Sep 21

EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Mylan CEO defends EpiPen cost to angry lawmakers

The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.

Sep 19

We all know generics are cheaper. But how much cheaper? Economists find a 38 to 48 percent decline in the prices of physician-administered drugs after the drugs' patents have expired. The decline is slightly lower for oral drugs.